Cargando…
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection
BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) number of death cases is still increasing. One of the comorbidities associated with severe outcome and mortality of COVID-19 is dyslipidemia. Statin is one of the drugs which is most commonly used for the treatment of dyslipidemic patients...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448951/ https://www.ncbi.nlm.nih.gov/pubmed/32882643 http://dx.doi.org/10.1016/j.dsx.2020.08.023 |